U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H12O2
Molecular Weight 212.2439
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Benzyl benzoate

SMILES

O=C(OCC1=CC=CC=C1)C2=CC=CC=C2

InChI

InChIKey=SESFRYSPDFLNCH-UHFFFAOYSA-N
InChI=1S/C14H12O2/c15-14(13-9-5-2-6-10-13)16-11-12-7-3-1-4-8-12/h1-10H,11H2

HIDE SMILES / InChI

Molecular Formula C14H12O2
Molecular Weight 212.2439
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://en.wikipedia.org/wiki/Benzyl_benzoate http://www.drugbank.ca/drugs/DB00676

Benzyl benzoate is an organic compound with the formula C6H5CH2O2CC6H5. It is the ester of benzyl alcohol and benzoic acid. It forms either a viscous liquid or solid flakes and has a weak, sweet-balsamic odor. It occurs in a number of blossoms (e. g. tuberose, hyacinth) and is a component of Balsam of Peru and Tolu balsam. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system. Benzyl benzoate is one of the older preparations used to treat scabies. Scabies is a skin infection caused by the mite sarcoptes scabiei. It is characterised by severe itching (particularly at night), red spots, and may lead to a secondary infection. Benzyl benzoate is lethal to this mite and so is useful in the treatment of scabies. It is also used to treat lice infestation of the head and body. Benzyl benzoate is not the treatment of choice for scabies due to its irritant properties. Benzyl benzoate exerts toxic effects on the nervous system of the parasite, resulting in its death. It is also toxic to mite ova, though its exact mechanism of action is unknown. In vitro, benzyl benzoate has been found to kill the Sarcoptes mite within 5 minutes.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Inactive ingredient
BRIGHTENING DYNAMICS TRAVELING KIT JAFRA

Approved Use

Helps prevent sunnburn. If used as directed, with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun.
Curative
BENZYL BENZOATE

Approved Use

Unknown

Launch Date

1976
Curative
BENZYL BENZOATE

Approved Use

Unknown

Launch Date

1976
Doses

Doses

DosePopulationAdverse events​
10 % 1 times / day multiple, topical
Dose: 10 %, 1 times / day
Route: topical
Route: multiple
Dose: 10 %, 1 times / day
Sources:
unhealthy, 4.7 years (range: 6 months - 15 years)
Health Status: unhealthy
Age Group: 4.7 years (range: 6 months - 15 years)
Sources:
Other AEs: Localised skin reaction...
Other AEs:
Localised skin reaction (12 patients)
Sources:
25 % 1 times / day multiple, topical
Dose: 25 %, 1 times / day
Route: topical
Route: multiple
Dose: 25 %, 1 times / day
Sources:
pregnant, adult
Health Status: pregnant
Age Group: adult
Sex: F
Sources:
AEs

AEs

AESignificanceDosePopulation
Localised skin reaction 12 patients
10 % 1 times / day multiple, topical
Dose: 10 %, 1 times / day
Route: topical
Route: multiple
Dose: 10 %, 1 times / day
Sources:
unhealthy, 4.7 years (range: 6 months - 15 years)
Health Status: unhealthy
Age Group: 4.7 years (range: 6 months - 15 years)
Sources:
PubMed

PubMed

TitleDatePubMed
Acaricidal activities of paeonol and benzoic acid from Paeonia suffruticosa root bark and monoterpenoids against Tyrophagus putrescentiae (Acari: Acaridae).
2006-06
Aluminum sulfate significantly reduces the skin test response to common allergens in sensitized patients.
2006-02-14
Crusted scabies in an adult T-cell leukemia/lymphoma patient successfully treated with oral ivermectin.
2006-02
Chemical-physical characterization and in vitro preliminary biological assessment of hyaluronic acid benzyl ester-hydroxyapatite composite.
2006-01
Deazapurine solid-phase synthesis: combinatorial synthesis of a library of N3,N5,C6-trisubstituted pyrrolo[3,2-d]pyrimidine derivatives on cross-linked polystyrene bearing a cysteamine linker.
2005-11-15
In vitro release of insulin and biocompatibility of in situ forming gel systems.
2005-11-04
Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants.
2005-10-29
Structure-activity studies of 3'-4'-dichloro-meperidine analogues at dopamine and serotonin transporters.
2005-10-01
Design of wide-spectrum inhibitors targeting coronavirus main proteases.
2005-10
Free radical generation during chemical depolymerization of heparin.
2005-09-15
Pthiriasis capitis.
2005-09
Oligonucleotides conjugated to short lysine chains.
2005-07-21
Food protective effect of acaricidal components isolated from anise seeds against the stored food mite, Tyrophagus putrescentiae (Schrank).
2005-06
Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation.
2005-05-13
Anti-cancer ProTides: tuning the activity of BVDU phosphoramidates related to thymectacin.
2005-05-02
Acaricidal activity of active constituent isolated in Chamaecyparis obtusa leaves against Dermatophagoides spp.
2005-03-23
SAR studies of brasilicardin A for immunosuppressive and cytotoxic activities.
2005-03-01
Floral scent emission and pollinator attraction in two species of Gymnadenia (Orchidaceae).
2005-02
Structure formation in injectable poly(lactide-co-glycolide) depots. II. Nature of the gel.
2005-01-15
Immunobiological [correction of Immunobioloical] activity of a new benzyl benzoate from the aerial parts of Solidago virga-aurea var. gigantea.
2005-01
Efficacy of various synthetic pyrethroid-impregnated encasement materials against house dust mite under laboratory conditions.
2005
In vitro release of levonorgestrel from phase sensitive and thermosensitive smart polymer delivery systems.
2005
Acaricidal activity of Paeonia suffruticosa root bark-derived compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
2004-12-29
Design, synthesis, and photochemical behavior of poly(benzyl ester) dendrimers with azobenzene groups throughout their architecture.
2004-12-24
In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.
2004-12-15
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting.
2004-11
The transmediastinal arteries of the human testis: an anatomical study.
2004-10
Drug release from injectable depots: two different in vitro mechanisms.
2004-09-30
Cytocompatibility and viscoelastic properties of phthalate ester-free tissue conditioners.
2004-09
3 dimensional modelling of early human brain development using optical projection tomography.
2004-08-06
[Nosocomial infection of scabies in national hospitals and sanatoria in Japan].
2004-07
Phytochemistry and preliminary biological evaluation of Cyathostemma argenteum, a malaysian plant used traditionally for the treatment of breast cancer.
2004-07
Rapid and sensitive quantitative analysis of alkyl phosphates in urine after organophosphate poisoning.
2004-06-11
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae).
2004-05-19
Genetic and molecular basis of grass cell-wall degradability. I. Lignin-cell wall matrix interactions.
2004-05
An evaluation of Hyalofill-F plus compression bandaging in the treatment of chronic venous ulcers.
2004-05
Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol.
2004-05
Synthesis of [323]-p-octiphenyls: orthogonal functionalization along a rigid-rod scaffold for refined supramolecular architecture.
2004-03-18
Controlled release of a model protein lysozyme from phase sensitive smart polymer systems.
2004-03-01
Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: assessment of weight gain, liver function, nutrient digestibility, wool production and meat quality.
2004-03
Effects of sarcoptic mange and its control with oil of Cedrus deodara, Pongamia glabra, Jatropha curcas and benzyl benzoate, both with and without ascorbic acid on growing sheep: epidemiology; assessment of clinical, haematological, cell-mediated humoral immune responses and pathology.
2004-03
p-Anisaldehyde: acaricidal component of Pimpinella anisum seed oil against the house dust mites Dermatophagoides farinae and Dermatophagoides pteronyssinus.
2004-03
Inhibition of alpha-chymotrypsin with thiol-bearing substrate analogues in the presence of zinc ion.
2004-02-09
The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs.
2004-02
Leaching of plasticizers from temporary denture soft lining materials.
2004-02
[Reconstruction of extensive soft tissue loss by transplantation of dermal and epidermal equivalents].
2004-01
The efficacy of benzyl benzoate sprays in killing the storage mite Tyrophagus putrescentiae (Acari: Acaridae).
2004
Controlling scabies in institutional settings: a review of medications, treatment models, and implementation.
2004
Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design.
2003-12-31
Gland cell cultures into 3D hyaluronan-based scaffolds.
2003-08
Patents

Sample Use Guides

30 mL of the lotion usually is sufficient for one application in adults and 20 mL usually is sufficient in children. The patient should bathe 24–48 hours after the last application to remove the drug.
Route of Administration: Topical
no mites were alive after 3 h exposure to 25% benzyl benzoate (Ascabiol)
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:50:46 GMT 2025
Edited
by admin
on Mon Mar 31 17:50:46 GMT 2025
Record UNII
N863NB338G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-8081
Preferred Name English
Benzyl benzoate
EP   FCC   FHFI   HSDB   II   INCI   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INCI  
Official Name English
SCABIOZON
Common Name English
BENZYL BENZOATE [EP IMPURITY]
Common Name English
BENZYL BENZOATE [MART.]
Common Name English
BENZYL BENZOATE [USP-RS]
Common Name English
BENZYL BENZOATE [USP MONOGRAPH]
Common Name English
BENZOIC ACID, BENZYL ESTER
Common Name English
Benzyl benzoate [WHO-DD]
Common Name English
BENZYLIS BENZOAS [WHO-IP LATIN]
Common Name English
BENZYL BENZOATE [II]
Common Name English
VENZONATE
Common Name English
BENZYL BENZOATE [ORANGE BOOK]
Common Name English
BENZYLOXY PHENYL KETONE
Systematic Name English
BENZYL BENZOATE [HSDB]
Common Name English
PHENYLMETHYL BENZOATE
Systematic Name English
BENZYL BENZOATE [USP IMPURITY]
Common Name English
BENZYL BENZOATE [MI]
Common Name English
BENZYL BENZOATE [FHFI]
Common Name English
BENZYL BENZOATE [EP MONOGRAPH]
Common Name English
BENZYL BENZOATE [FCC]
Common Name English
BENZYL BENZOATE [WHO-IP]
Common Name English
BENZYLBENZENECARBOXYLATE
Systematic Name English
BENZYL BENZOATE [JAN]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 172.515
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
WHO-ATC P03AX01
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION SCCS/1459/11
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 13.5
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
JECFA EVALUATION BENZYL BENZOATE
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
EPA PESTICIDE CODE 9501
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
WHO-VATC QP53AX11
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
Code System Code Type Description
EVMPD
SUB13023MIG
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
ECHA (EC/EINECS)
204-402-9
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
EPA CompTox
DTXSID8029153
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
MERCK INDEX
m2400
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY Merck Index
NSC
8081
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
CAS
120-51-4
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
ChEMBL
CHEMBL1239
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
ALANWOOD
benzyl benzoate
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
JECFA MONOGRAPH
309
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
PUBCHEM
2345
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
HSDB
208
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
FDA UNII
N863NB338G
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
NCI_THESAURUS
C65255
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
RS_ITEM_NUM
1062008
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
SMS_ID
100000091327
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
MESH
C006723
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
CHEBI
41237
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
BENZYL BENZOATE
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY Description: A clear, colourless, oily liquid; odour, faintly aromatic. Miscibility: Practically immiscible with water and glycerol R; miscible with ethanol (~750 g/l) TS and ether R. Category: Scabicide (topical use). Storage: Benzyl benzoate should be kept in a tightly closed and well-filled container, protected from light. Additional information: Benzyl benzoate may slowly decompose on contact with air. Definition: Benzyl benzoate contains not less than 98.0% and not more than 100.5% of C14H12O2.
DRUG CENTRAL
335
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
WIKIPEDIA
BENZYL BENZOATE
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
RXCUI
19044
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY RxNorm
DRUG BANK
DB00676
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
DAILYMED
N863NB338G
Created by admin on Mon Mar 31 17:50:46 GMT 2025 , Edited by admin on Mon Mar 31 17:50:46 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT MAY BE PRESENT
Related Record Type Details
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY
http://apps.who.int/phint/pdf/b/Jb.6.1.51.pdf